BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 28403876)

  • 1. Development of a core outcome set for effectiveness trials aimed at optimising prescribing in older adults in care homes.
    Millar AN; Daffu-O'Reilly A; Hughes CM; Alldred DP; Barton G; Bond CM; Desborough JA; Myint PK; Holland R; Poland FM; Wright D;
    Trials; 2017 Apr; 18(1):175. PubMed ID: 28403876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a core outcome set for clinical trials aimed at improving antimicrobial stewardship in care homes.
    Nguyen HQ; Bradley DT; Tunney MM; Hughes CM
    Antimicrob Resist Infect Control; 2021 Mar; 10(1):52. PubMed ID: 33750479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Norwegian General Practice--Nursing Home criteria (NORGEP-NH) for potentially inappropriate medication use: A web-based Delphi study.
    Nyborg G; Straand J; Klovning A; Brekke M
    Scand J Prim Health Care; 2015 Jun; 33(2):134-41. PubMed ID: 26100966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of a Core Outcome Set for medicines management interventions for people with dementia in primary care.
    McGrattan M; Barry HE; Ryan C; Cooper JA; Passmore AP; Robinson AL; Molloy GJ; Darcy CM; Buchanan H; Hughes CM
    Age Ageing; 2019 Mar; 48(2):260-266. PubMed ID: 30395183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'.
    Prinsen CA; Vohra S; Rose MR; King-Jones S; Ishaque S; Bhaloo Z; Adams D; Terwee CB
    Trials; 2014 Jun; 15():247. PubMed ID: 24962012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Core Outcome Set for Trials Aimed at Improving the Appropriateness of Polypharmacy in Older People in Primary Care.
    Rankin A; Cadogan CA; In Ryan C; Clyne B; Smith SM; Hughes CM
    J Am Geriatr Soc; 2018 Jul; 66(6):1206-1212. PubMed ID: 29461621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.
    Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK;
    Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis.
    Tallouzi MO; Mathers JM; Moore DJ; Murray PI; Bucknall N; Blazeby JM; Calvert M; Denniston AK
    Trials; 2017 Dec; 18(1):576. PubMed ID: 29191216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions to optimise prescribing for older people in care homes.
    Alldred DP; Raynor DK; Hughes C; Barber N; Chen TF; Spoor P
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009095. PubMed ID: 23450597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions to optimise prescribing for older people in care homes.
    Alldred DP; Kennedy MC; Hughes C; Chen TF; Miller P
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD009095. PubMed ID: 26866421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A core outcomes set for clinical trials of interventions for young adults with type 1 diabetes: an international, multi-perspective Delphi consensus study.
    Byrne M; O'Connell A; Egan AM; Dinneen SF; Hynes L; O'Hara MC; Holt RIG; Willaing I; Vallis M; Hendrieckx C; Coyne I
    Trials; 2017 Dec; 18(1):602. PubMed ID: 29258565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a core outcome set for the evaluation of interventions to prevent COVID-19 in care homes (COS-COVID-PCARE Study).
    Shepherd V; Islam I; Wood F; Williamson PR; Goodman C; Bath PM; Thompson C; Knapp M; Gordon AL; Hood K
    BMC Geriatr; 2022 Aug; 22(1):710. PubMed ID: 36028791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting.
    Langbroek GB; Wolkerstorfer A; Horbach SER; Spuls PI; Kelly KM; Robertson SJ; van Raath MI; Al-Niaimi F; Kono T; Boixeda P; Laubach HJ; Badawi AM; Rubin AT; Haedersdal M; Manuskiatti W; van der Horst CMAM; Ubbink DT;
    Br J Dermatol; 2022 Nov; 187(5):730-742. PubMed ID: 35762296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care homes: the CHIPPS study.
    Bond CM; Holland R; Alldred DP; Arthur A; Barton G; Blyth A; Desborough J; Ford J; Handford C; Hill H; Hughes CM; Maskrey V; Massey K; Myint PK; Norris N; Poland FM; Shepstone L; Turner D; Zermansky A; Wright D;
    Trials; 2020 Jan; 21(1):103. PubMed ID: 31964398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol).
    Kirkham JJ; Gorst S; Altman DG; Blazeby J; Clarke M; Devane D; Gargon E; Williamson PR;
    Trials; 2015 Aug; 16():373. PubMed ID: 26297658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.
    Chiarotto A; Terwee CB; Deyo RA; Boers M; Lin CW; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
    Trials; 2014 Dec; 15():511. PubMed ID: 25540987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Metric to Detect and Decrease Low-Value Prescribing in Older Adults.
    Radomski TR; Decker A; Khodyakov D; Thorpe CT; Hanlon JT; Roberts MS; Fine MJ; Gellad WF
    JAMA Netw Open; 2022 Feb; 5(2):e2148599. PubMed ID: 35166780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIPc study: development of indicators of potentially inappropriate prescribing in children (PIPc) in primary care using a modified Delphi technique.
    Barry E; O'Brien K; Moriarty F; Cooper J; Redmond P; Hughes CM; Bennett K; Fahey T; Smith SM;
    BMJ Open; 2016 Sep; 6(9):e012079. PubMed ID: 27601499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What outcomes should be measured in feline chronic kidney disease treatment trials? Establishing a core outcome set for research.
    Doit H; Dean RS; Duz M; Finch NC; Brennan ML
    Prev Vet Med; 2021 Jul; 192():105348. PubMed ID: 34022713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.